AzTrials
AzTrials

Refeeding SyndromeRFSNCT03141489

Refeeding Syndrome Among Older Adults

A study testing Tubefeeding in people with Refeeding Syndrome, run by Diakonhjemmet Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Malnutrition is highly prevalent among older adults. Adequate treatment is crucial to maintain health, improve functional status and independency. For severely malnourished patient, tube feeding is often the most effective treatment, but it also implies a risk of developing refeeding syndrome (RFS). Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Refeeding Syndrome
What is being tested?
Tubefeeding
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteNorway
Study dates
10 Apr 2017to 8 Oct 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Malnourished: According to NICE screening tool:
  • BMI <16kg/m2, or weight loss, or little nutritional intake, Or: BMI< 18.5kg/m2, and; weight loss, or little nutritional intake, or alcohol, drug abuse, chemotherapy, antacids diuretics.

Who cannot join

  • Severe dementia (palliative stage).
  • Severe kidney disease, or congestive heart failure NYHA class III or IV(medical doctor to decide if patient is eligible for inclusion)
  • Already on artificial nutrition
  • Terminal stage of life, defined as receiving only palliative medical treatment
  • Readmissions (patients will not be included twice)
  • Intensive care patients.

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Diakonhjemmet Hospital

    Oslo, Postboks 23 Vinderen, 0319

Other trials in Norway

About this study

Official title: Safe Refeeding of Severely Malnourished Patients 65 Years or Older

Malnutrition is highly prevalent among older adults. Adequate treatment is crucial to maintain health, improve functional status and independency. For severely malnourished patient, tube feeding is often the most effective treatment, but it also implies a risk of developing refeeding syndrome (RFS). RFS is described as fluid and electrolyte shifts particular hypophosphatemia when recommencing nutrition, potentially causing fatal complications. In 2006 National Institute for Health and Care Excellence (NICE) developed guidelines regarding 1) detecting patients at risk for RFS and 2) a treatment plan for refeeding severely malnourished patients. These guidelines have never been validated. Hence, there is a need to explore the use of different refeeding regimens in the treatment of older malnourished patients, in regards to assess safety, as well as the impact of the treatment, on functional status, independency, quality of life and RFS. This will be the first randomized controlled trial (RCT) that challenges the existing NICE guidelines. A blinded RCT study, with the aim of tube feeding patients at risk for developing RFS, and assigned either to an intervention group or to a control group, comparing the different refeeding regimens. This study will help develop safe and validated refeeding protocols for severely malnourished older patients.

Read the detailed description

Before 2006, the recommended initial refeeding rate was around 20-25kcal/kg/day for severely malnourished patients. But due to the risk of RFS, the National Institute of Health and Clinical Excellence (NICE) in 2006 published new guidelines, recommending a very cautious refeeding level of only 5-10 kcal/kg/day. However, the supporting literature underpinning the evidence that results in the above recommendations is weak, and is mostly based upon cohort studies, case series and consensus expert opinions. RFS was first identified and reported on in the late forties when starved concentration camp inmates and prisoners of war developed cardiac arrest, neuralgic symptoms and/or peripheral edema during recommencement of feeding. Similar symptoms were noticed again during the 1970's and 1980's, when parenteral nutrition was used widely, and carbohydrate provision was not restricted.

Patients defined as at risk for RFS are those who are malnourished and have recently lost weight. In addition, patients with, eating disorders, uncontrolled diabetes, cancer, malabsorption syndromes, alcoholics, surgical patients, elderly, and patients who are fasting or have undergone bariatric surgery, are high risk groups. It is well known that low levels of electrolytes are fatal, and may cause cardiac-and lung problems, affect the gastrointestinal-and the immune system, and increase the occurrence of sepsis and infections. Even severely malnourished patients have normal electrolyte levels upon admission, but when refeeding, a rapid drop in electrolytes, especially phosphate, may occur, usually within 2-5 days. Electrolytes like potassium and sodium are measured routinely, but magnesium and phosphate are not included in routine laboratory tests, and therefore often overlooked. Studies have found that patients screened as "not at risk" also develop RFS confirming the need for monitoring phosphate levels on a broader group than just patients at risk. Two main challenges regarding RFS are the absence of a clear definition and the uncertainties regarding the optimal refeeding rate. However, new onset hypophosphatemia after refeeding is a good predictor of RFS and will be used in this study when defining RFS.

Refeeding syndrome in Anorexia Nervosa:

Most studies on RFS conducted on patients with eating disorders, but few are Randomized Controlled Trials (RCT). In later years there has been a paradigm shift in regards to refeeding patients with anorexia nervosa (AN). For years, a low calorie approach has been recommended, but these recommendations has led to poor weight gain and prolonged hospital stay. Garber et al. did a systematic review on refeeding patients with AN, and concluded that higher calorie approaches on AN patients in hospital is feasible, when close medical monitoring is provided. Studies on patients with eating disorders indicate that the severity of malnutrition rather than the total energy intake predict the development of RFS. For instance a calorie level at both 125 and 1900 kcal a day led to hypophosphatemia. The great difference in recommendation for initial refeeding rates in patients with eating disorders, illustrates the lack of studies and international consensus on the topic.

Older adults and refeeding syndrome:

Overall only a few studies are done on tube feeding (TF) in older adults with the aim of improving nutritional status. Regarding RFS and older adults, there are only six clinical trials, but none of them RCT's. These trials are mostly looking at occurrence of RFS, and they all use different cut off levels when defining hypophosphatemia (HP). In addition, they all used different outcomes measures; either mortality rates, delirium or muscle strength, which in the end makes it difficult to compare the studies.

When refeeding malnourished patients the effect on physical function is often the first sign of improvement. Hand grip strength (HGS) is a relevant marker of physical function, and has been shown to be a legitimate indicator of nutritional status. In some populations HGS may even predict outcomes better than traditional nutritional markers such as weight to height ratios, weight loss or limb circumference . Reduced HGS is associated with increased LoS), increased risk of complication, premature mortality and earlier onset of dependency. Recently a study has shown that lower HGS at discharge is associated with higher 30-day readmission rate, and might be a useful indicator to detect patient at risk of readmission, and the need for individualize discharge planning including nutrition care.

Although it is reported that refeeding too cautiously can place patients at even further risk of malnutrition, postpone recovery and lead to unnecessary loss of physical function but NICE has stated that guidelines cannot be changed unless more high-quality RCTs are performed. This study will provide new knowledge regarding how to refeed severely malnourished elderly patients. By providing them with 40% more calories and protein the first 7 days of hospitalization one can expect faster improvements in regards to physical function, independency, reduced readmission-and mortality rates. In addition this study provides new knowledge regarding the necessity to monitor phosphate levels in patients not identified as at risk of developing RFS.

Hypothesis: The investigators hypothesize that providing a higher initial refeeding rate, reaching estimated calorie and protein needs faster, is as safe as following NICE guidelines. Furthermore, the investigators hypothesize that the intervention group will improve HGS, and achieve a better long-term effects compared to the control group.

Study aims are to:

  1. Investigate if a high initial refeeding rate is safe and leads to improvement of the patient's physical function and independency compare to a slower refeeding rate?
  2. Evaluate the long-term effects three months after discharge between two different refeeding regimens regarding physical function, independency, quality of life, mental test score, readmission and mortality rates

Feasibility of the study:

Regarding the feasibility of the project: it will be carried out on all medical and surgical wards at Diakonhjemmet hospital. Refeeding of patients using tube feeding is part of routine care. The study is already approved by the Regional Ethic Committee (REC) and the head of the departments at Diakonhjemmet hospital have been informed and approved the research project.

Refeeding guidelines forms are premade based on kg and type of intervention (fast or slow) and will be inserted as phrases in the electronic medical journal.

Regarding recruitment of patients, it is estimated to include 1.5 patients a week (63 patients in a year based on 42 recruiting weeks in a year). The estimation is based on a point prevalence of malnutrition performed in 2016, where 12 patients out of the 72 screened patients 65 years and older (16.7%), had BMI <18.5. The calculation was based on a 10 % agreement of participation. To be even more cautious the investigators estimates a recruitment of 126 patients ,within 3 years, based on patients accessibility of 4000 new admissions a year.

During the study period there will be regular meetings with the supervisors and the project coordinator, located at the same ward.

A research assistant (RA) will perform the physical test and questionnaires, in hospital and at 3 months

Publications:

  1. Will a higher initial refeeding rate, meeting estimated calories and protein needs faster, in severely malnourished older patients affect patient's handgrip strength?
  2. Effects of two different refeeding regimes in severely malnourished older patients admitted to hospital in regards to physical function, cognition, quality of life, activities of daily living, and readmission and mortality rates.
  3. The difference in occurrence of electrolyte disturbances comparing two refeeding regimes in severely malnourished older patients admitted to hospital.

Statistics Statistics The sample size estimation is performed using HGS as the primary endpoint. A clinically important difference was defined as a mean difference in HGS of 1 kg between baseline and follow up between the two treatment groups. Then, if the true mean difference in the intervention and control group in HGS between baseline and follow up is 1 kg with an estimated standard deviation of 1.8, the investigator will need to study a minimum of 52 patients in each treatment group, a total of 104 patients, considering a type I error of 5% and a power of 80%. Due to possible drop-outs the sample size will be increased with 20 %, which gives a total of 126 patients i.e. 63 patients in each group.

Statistical analysis will be performed using SPSS version 20. Data will be presented as the mean and standard deviation (SD) for continuous variables and as percentages for categorical variables. Differences between the intervention group and control group will be assessed by t-tests for continuous data, with non-parametric test for ordinal data and with the chi-squared test for categorical data. The main statistical assessment of primary and secondary endpoint with repeated measurements will be mixed models for repeated measurements.

The data will be analysed following the intention to treat principles and all the randomized patients will be included in the analyses. LoS will be calculated as the difference between the day of admission and the day of hospital discharge.

User involvement The project is presented to and discussed with the User Committee (UC) at Diakonhjemmet Hospital. This study will recruit a very heterogenic patient group, which makes it difficult to find suitable users. In that matter, the UC has been chosen to represent the patients. UC has approved the project as they considers it to be clinically relevant and benefit for the users, and further supports an application. UCs representatives made important contributions regarding the target group of the project. The UC have raised concerns regarding patients with dementia making sure that their integrity is cared for throughout the study. The UC also emphasized patients degree of dementia, and the importance to reflect critically and continually on the participative process. It is important that they understand the nature of the research and his /her participation. In addition that patients with dementia, shows the ability to consider alternatives, including the option not to participate in the study. Another concern from the UC is the older adults without dementia that might feel obligated to sign the informed consent and the need for the researcher to clearly state that this is voluntary.

UC has also provided input to the consent form to ensure clear and user-friendly language.

This project will be presented to the UC at their meetings in 2016 and will be regularly informed of the progress and given the opportunity to provide input and advice.

The PhD candidate will attend a course in "User involvement in research and service design" to strengthen her expertise and ensure the safeguarding of the user's role and participation in the research project (25th of May 2016).

Being tested
Tubefeeding
Medical subject headings
Refeeding Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TubefeedingDietary supplement

    Also called fed by a feeding tube

    NICE guidelines regarding refeeding syndrome, based on a very cautious refeeding regime reaching estimated calorie and protein needs within 7 days, compared to a protocol at Diakonhjemmet Hospital using a higher starting rate, reaching estimated needs within 3 days.

Study groups in NCT03141489
Study groupRoleWhat they receive
NICE guidelines for refeeding syndromeExperimentalHigh protein enteral tubefeeding solution. NICE guidelines regarding refeeding syndrome, based on a very cautious refeeding regime reaching estimated calorie and protein needs within 7 days, compared to a protocol at Diakonhjemmet Hospital using a higher starting rate, reaching estimated needs within 3 days.
Receives: Dietary Supplement: Tubefeeding
Diakonhjemmet Hospital Protocol(DS)ExperimentalHigh protein enteral tubefeeding solution. The intervention group, Diakonhjemmets feeding protocol, will start at 20 calories a kg a day, and increasing until estimated needs are met within 3days
Receives: Dietary Supplement: Tubefeeding

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Hand grip strength

    Using Jamar Pluss Digital +, Measuring change in kg from baseline, day 4, 7 and at 3months.

    Measured: Baseline and at three months.

Secondary outcomes (8)
  1. EQ-5D-5L

    Health related quality of life. Questionnaires

    Measured: Day 4 and after 3 months

  2. Alertness, attention, acute change, and abbreviated mental test (The 4AT),

    Screening instrument for cognitive impairment and delerium.

    Measured: Day 4 and after 3 months

  3. Mortality

    Mortalityrates during and after 3 months

    Measured: register mortality after 3 months and 1-year

  4. Readmission rates

    Readmission of patients in the study

    Measured: Readmissionrates after 30 days

  5. Weight measurement

    Measuring bodyweight during patients hospital stay, starting at day one of tubefeeding, and then day 4 and on day 7, and at 3 months after last tubefeeding day (with approximatly one week discrepancy)

    Measured: Day 1, day 4 and on day 7 after staring with tubefeeding in hospital, and at 3 months

  6. Infection

    Diagnosis set by a medical doctor. C-reactive protein (CRP), erythrocytes, sedimentation rate (ESR), white blood cells (WBC), and differential leukocyte count.

    Measured: Labratory values are measured daily, and assessed for infections. Baseline and day 2,3,4,5,6,7.

  7. Hospital length of stay (LoS)

    Defined as the total number of hospital days before discharge, either to a nursing home, home with homecare or home without further assistance.

    Measured: From the day of admission until the day of discharged up to 3 months.

  8. Number and type of complication when refeeding

    Complications might be: constipation, edema, nausea and vomiting, hypoglycemia and cardiac abnormalities, and tubedislocation

    Measured: Number of complications on predefined refeeding day 7.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2017
  2. Study start10 Apr 2017
  3. Primary completion6 Aug 2019
  4. Study completion8 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Factorial
Model description
Refeeding protocol: Standardised refeeding protocols will be used for each of the patient groups; the control group will start tube feeding at 5 or 10 kcal/kg/day depending on their BMI and increase until needs are met within 7 days. The intervention group will start tube feeding at 20 kcal/kg/day and increase until needs are met within 3 days, but continue feeding minimum of 7days. Electrolytes will be monitored daily The patients will receive100 mg thiamine, and 1 multivitamin/mineral daily, all recorded in the medical journal. The intervention group will receive approximately 40% higher amount of protein and calories compared to the control group in the end of day 7.
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03141489
Sponsor's protocol ID
2017/FO148295
Acronym
RFS
Status last verified
Sep 2021
First submitted
17 Feb 2017
Last updated
27 Sep 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Olsen SU, Tazmini K, Aas AM, Ranhoff AH, Pripp AH, Hesseberg K, Sunde S, Bye A. The incidence and mortality of refeeding syndrome in older hospitalized patients, based on three different diagnostic criteria: A longitudinal study. Clin Nutr ESPEN. 2024 Jun;61:101-107. doi: 10.1016/j.clnesp.2024.03.006. Epub 2024 Mar 15.

    PubMed 38777421

Questions about this trial

What is this clinical trial studying?

A study testing Tubefeeding in people with Refeeding Syndrome, run by Diakonhjemmet Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Hand grip strength (time frame: Baseline and at three months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03141489, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in